IMPROVED GLYCAN-DEPENDENT CHIMERIC ANTIGEN RECEPTOR CELLS

Fecha de publicación: --
Fuente: WIPO "tomato"
Provided are compositions and methods for treating diseases associated with aberrant glycosylation of cell surface molecules and expression of tumor-associated carbohydrate antigens (TACA). Also provided are chimeric antigen receptors (CARs) specific to tumor-associated carbohydrate antigens (TACA-CARs), vectors encoding the TACA-CARs, and recombinant cells comprising the TACA CARS.